Get Your Personalized Supplement StackSupplement Stack Quiz

SEMAX HD Proprietary Blend

Also known as: Semax, Met-Glu-His-Phe-Pro-Gly-Pro, Semax HD Proprietary Blend

Overview

Semax is a synthetic heptapeptide analogue of the N-terminal fragment (4-10) of adrenocorticotropic hormone (ACTH), designed to mimic and enhance neurotropic and neuroprotective effects. It is not naturally occurring but is based on a natural hormone fragment. Primarily used for cognitive enhancement, neuroprotection, and potentially in the treatment of neurological disorders, Semax is typically administered intranasally. Research indicates that Semax increases brain-derived neurotrophic factor (BDNF) levels in the brain, a crucial factor for synaptic plasticity and cognitive function. However, the research maturity level is moderate, with most evidence stemming from preclinical and small clinical studies. Large-scale randomized controlled trials (RCTs) and systematic reviews specifically on Semax HD proprietary blend are limited, necessitating further rigorous investigation to validate its efficacy and safety in humans. The Semax HD proprietary blend likely contains the Semax peptide but may include other ingredients.

Benefits

Semax has demonstrated the ability to increase BDNF protein levels in the basal forebrain, which is associated with improved learning and memory formation, primarily observed in rodent models and some human studies. This increase in BDNF suggests potential neuroprotective effects, which could be beneficial in managing cognitive disorders. However, the evidence supporting these benefits is primarily derived from preclinical studies and small human trials. The effect sizes and clinical significance of Semax are not yet definitively established due to the lack of large-scale, high-quality clinical trials. The time course of these benefits shows that BDNF levels can increase within 3 hours following intranasal administration in animal models.

How it works

Semax primarily acts by binding to specific receptors in the basal forebrain, a process that requires calcium ions. This binding stimulates the synthesis of brain-derived neurotrophic factor (BDNF), a key modulator of synaptic plasticity and neuronal survival. By increasing BDNF levels, Semax influences the central nervous system, particularly in brain regions involved in cognition, learning, and memory. Intranasal administration allows Semax to bypass the blood-brain barrier, facilitating rapid uptake into the brain. The interaction with BDNF pathways and specific receptor binding sites in the basal forebrain are the primary mechanisms through which Semax exerts its effects.

Side effects

Due to limited clinical data, the safety profile of Semax is not fully established. Common, uncommon, and rare side effects are not well-documented in peer-reviewed literature. There are no well-documented drug interactions or established contraindications. Special population considerations are also lacking due to insufficient data. Some adverse effects have been reported in human studies, but these have not been extensively characterized. Therefore, caution is advised when considering Semax, and further research is needed to comprehensively assess its safety profile. Individuals should consult with a healthcare professional before using Semax, especially if they have pre-existing medical conditions or are taking other medications.

Dosage

The minimum effective dose of Semax, based on animal studies, is around 50 to 250 µg/kg bodyweight when administered intranasally, which has been shown to increase BDNF levels. However, optimal dosage ranges and maximum safe doses have not been established for humans. Effects on BDNF levels have been observed within 3 hours post-administration in animal models. Intranasal administration is the preferred method for achieving central nervous system effects. Calcium ions are required for receptor binding, which is crucial for Semax's mechanism of action. Due to the limited human data, it is essential to approach Semax usage with caution and consult with a healthcare professional to determine appropriate and safe dosage levels.

FAQs

Is Semax HD proprietary blend the same as Semax?

The proprietary blend likely contains Semax peptide but may include other ingredients; however, no independent peer-reviewed studies on the proprietary blend as a whole were found.

Is Semax safe?

Limited safety data; some adverse effects reported but not well characterized. More research is needed to fully understand the safety profile of Semax.

How quickly does Semax work?

Animal studies show BDNF increase within 3 hours of intranasal administration, suggesting a relatively rapid onset of action, though human data is limited.

Does Semax improve cognition?

Preclinical evidence suggests potential cognitive benefits via BDNF modulation, but more human studies are needed to confirm these effects.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/16635254/ – This preclinical animal study (Dolotov et al., 2006) found that Semax binds specifically to basal forebrain receptors and significantly increases BDNF protein levels after intranasal administration in rats. The study demonstrated that Semax requires calcium ions for receptor binding and stimulates BDNF synthesis, suggesting a mechanism for its potential neuroprotective and cognitive-enhancing effects. However, the findings are limited by the animal model and lack of direct clinical relevance.
https://www.innerbody.com/semenax-reviews – This is a review website that discusses Semenax, a male enhancement supplement, and is not directly related to Semax or the Semax HD proprietary blend. It provides information on the ingredients, potential benefits, and customer reviews of Semenax, but does not offer scientific research or clinical data on Semax.
http://cd.textfiles.com/thegreatunsorted/zines_and_groups/zines_m-z/ad-words.txt – This is a text file containing a list of advertising keywords and is not a scientific research source. It does not provide any information or data related to Semax or the Semax HD proprietary blend.